Plaque Psoriasis

Topical tapinarof cream showed significant improvement of moderate to severe atopic dermatitis while being well tolerated by adults and children down to age 2 years, according to two phase 3 clinical trials.

Simlandi injection, an interchangeable biosimilar to Humira, is now available in the U.S. for the treatment of psoriatic arthritis, plaque psoriasis and other conditions, Teva Pharmaceuticals and Alvotech announced in a press release.

Bristol Myers Squibb announced results from its long-term extension trial of Sotyktu for the treatment of adults with moderate to severe plaque psoriasis, according to a press release.

In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into psoriasis from the American Academy of Dermatology Annual Meeting, examining results from the phase 2 STRIDE study.

The FDA has approved Selarsdi as a biosimilar to Stelara for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis, Teva Pharmaceuticals and Alvotech announced in a press release.

Once-daily roflumilast cream 0.3% was well tolerated and efficacious in the long-term treatment of patients with plaque psoriasis, suggesting it is suitable for chronic treatment, according to a study.

In this Healio exclusive video, Steven R. Feldman, MD, PhD, discussed study results presented at the American Academy of Dermatology Annual Meeting examining bimekizumab in the treatment of psoriasis.

In this Healio exclusive video, Steven R. Feldman, MD, PhD, discussed psoriasis research from the phase 2 STRIDE study presented at the American Academy of Dermatology Annual Meeting.

In this Healio exclusive video, Steven R. Feldman, MD, PhD, discussed psoriasis research from the phase 2 KNOCKOUT study presented at the American Academy of Dermatology Annual Meeting.

In this Healio exclusive video, Steven R. Feldman, MD, PhD, discussed psoriasis research from the American Academy of Dermatology Annual Meeting examining the LITE study in plaque-type psoriasis.